Kaplan-Meier survival curves of patients with stage II and III CRC. (A)... | Download Scientific Diagram
Colorectal cancer in South Africa: An assessment of disease presentation, treatment pathways and 5-year survival
Cetuximab as salvage monotherapy in chemotherapy‑refractory metastatic colorectal cancer: A single‑center report
Clinical characteristics and survival profile of young versus old colorectal cancer patients at a tertiary cancer center in North India over a period of 5 years Vasudevan S, Mehta A - Indian
Cureus | Pre-Diagnosis Aspirin Use Has No Effect on Overall Survival in Patients With Colorectal Cancer: A Study of a Multi-Racial Population
Study Finds Colorectal Cancer Survival Rates Significantly Lower in Low-Income Countries in Sub-Saharan Africa
Informing metastatic colorectal cancer patients by quantifying multiple scenarios for survival time based on real‐life data - Hamers - 2021 - International Journal of Cancer - Wiley Online Library
Cancers | Free Full-Text | Trends in Overall Survival and Treatment Patterns in Two Large Population-Based Cohorts of Patients with Breast and Colorectal Cancer | HTML
Overall survival between IBD with CRC (n = 63, green line) versus... | Download Scientific Diagram
Comprehensive analysis of prognostic immune-related genes in the tumor microenvironment of colorectal cancer | Aging
Cancers | Free Full-Text | Colorectal Cancer Presentation and Survival in Young Individuals: A Retrospective Cohort Study | HTML
Metformin selectively inhibits metastatic colorectal cancer with the KRAS mutation by intracellular accumulation through silencing MATE1 | PNAS
Erratum: Ferroptosis-related Genes for Overall Survival Prediction in Patients with Colorectal Cancer can be Inhibited by Gallic acid
Prognostic nomograms for predicting overall survival and cause-specific survival of signet ring cell carcinoma in colorectal cancer patients
Dietary factors and polymorphisms in vitamin D metabolism genes: the risk and prognosis of colorectal cancer in northeast China | Scientific Reports
CCL21 as an independent favorable prognostic factor for stage III/IV colorectal cancer
FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial | British Journal of Cancer
Overall and stage-specific survival of patients with screen-detected colorectal cancer in European countries: A population-based study in 9 countries - The Lancet Regional Health – Europe